echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Network Open: ADHD drugs may reduce children's suicide risk!

    JAMA Network Open: ADHD drugs may reduce children's suicide risk!

    • Last Update: 2021-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Globally, the suicide rate of children has been steadily increasing
    .
    According Disease Prevention Control Center data show that 2018 years, 10 Zhi 24- year olds, suicide is the second leading cause of death


    .


    Globally, the suicide rate of children has been steadily increasing


    CCO

    CCO

    ADHD starts in childhood and can continue to affect adulthood.
    Its main characteristics are attention deficit and/or hyperactivity impulsive that are not commensurate with the level of development


    .


    ADHD starts in childhood and can continue to affect adulthood.


    In this cohort study, the researchers used data from the American Adolescent Brain Cognitive Development (ABCD) study.


    The large amount of data and breadth collected in the ABCD study enabled the research team to control multiple confounding factors and specifically analyze ADHD drugs and suicide.
    The relationship between tendencies
    .


    In this cohort study, the researchers used data from the American Adolescent Brain Cognitive Development (ABCD) study.


    The results showed that with no and no suicidal tendencies compared to the children, showing suicidal children to have more ADHD -like symptoms, and are more likely to accept ADHD suicidal compared to children, showing suicidal children have more the ADHD -like symptoms, and more likely to accept ADHD medications


    In order to study whether this effect is long-lasting, the researchers analyzed follow-up data after 1 year and found that children with severe ADHD -like symptoms who received ADHD medication at baseline were less likely to commit suicide after 1 year .
    Children who did not receive ADHD medication at baseline but had severe ADHD -like symptoms were more likely to commit suicide one year later .

    In order to investigate whether this effect lasting, researchers analyzed 1 year follow-up data found acceptance at baseline at baseline receiving ADHD medication ADHD -like symptoms severe children 1 year after less likely to commit suicide


    .


    Researchers said that the use of ADHD drugs in children can be used for early diagnosis and treatment, especially in children with severe ADHD -like symptoms, which can not only improve learning and behavior problems, but also reduce the risk of suicide


    .


    Researchers said that the use of ADHD drugs in children can be used for early diagnosis and treatment, especially in children with severe ADHD -like symptoms, which can not only improve learning and behavior problems, but also reduce the risk of suicide
    .


    In summary, this study revealed that this study revealed that ADHD drugs are associated with lower suicide rates in children with high ADHD -like symptoms, both in men and women


    Original source

    Gal Shoval, MD 1,2 ;Elina Visoki, MSc 3,4 ;Tyler M.
    Moore, PhD 4,5 ;et al .
    Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children .
    JAMA Network Open(2021).
    DOI: 10.
    1001/jamanetworkopen.
    2021.
    11342

    Gal Shoval, MD 1,2 1,2 1,2 ;Elina Visoki, MSc 3,4 ;Tyler M.
    Moore, PhD 4,5 ;Elina Visoki, MSc 3,4 3,4 Tyler M.
    Moore, PhD 4, 5 4,5 et al .
    Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children .
    JAMA Network Open Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children JAMA Network Open  (2021 ).
      DOI: 10.
    1001/jamanetworkopen.
    2021.
    11342 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.